StockData
Zimmer Biomet Holdings, Inc. logo

Zimmer Biomet Holdings, Inc. (ZBH) stock

ZBHNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3016% below fair value
$103.32+1.23 (+1.20%)

Close on Nov 18, 2026Market cap $19.71BP/E 25.1Yield 0.93%

Zimmer Biomet revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Zimmer Biomet's revenue for the twelve months ending Jun 30, 2026 was $8.51B, up 8.6% year over year. For fiscal 2025 it was $8.23B, up 7.2% from the year before. Over ten years it grew 3.2% a year on average. The highest annual figure on record is $8.23B in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$8.23B+7.2%
FY2024Dec 31, 2024$7.68B+3.8%
FY2023Dec 31, 2023$7.39B+6.5%
FY2022Dec 31, 2022$6.94B+1.6%
FY2021Dec 31, 2021$6.83B+11.4%
FY2020Dec 31, 2020$6.13B-23.2%
FY2019Dec 31, 2019$7.98B+0.6%
FY2018Dec 31, 2018$7.93B+1.7%
FY2017Dec 31, 2017$7.80B+1.8%
FY2016Dec 31, 2016$7.67B+27.9%
FY2015Dec 31, 2015$6.00B+28.3%
FY2014Dec 31, 2014$4.67B+1.1%
FY2013Dec 31, 2013$4.62B+3.4%
FY2012Dec 31, 2012$4.47B+0.4%
FY2011Dec 31, 2011$4.45B+5.5%
FY2010Dec 31, 2010$4.22B+3.0%
FY2009Dec 31, 2009$4.10B-0.6%
FY2008Dec 31, 2008$4.12B+5.7%
FY2007Dec 31, 2007$3.90B–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$2.18B+4.8%
Q1 FY2026Mar 31, 2026$2.09B+9.3%
Q4 FY2025Dec 31, 2025$2.24B+10.9%
Q3 FY2025Sep 30, 2025$2.00B+9.7%
Q2 FY2025Jun 30, 2025$2.08B+7.0%
Q1 FY2025Mar 31, 2025$1.91B+1.1%
Q4 FY2024Dec 31, 2024$2.02B+4.3%
Q3 FY2024Sep 30, 2024$1.82B+4.0%
Q2 FY2024Jun 30, 2024$1.94B+3.9%
Q1 FY2024Mar 31, 2024$1.89B+3.2%
Q4 FY2023Dec 31, 2023$1.94B+6.3%
Q3 FY2023Sep 30, 2023$1.75B+5.0%
Q2 FY2023Jun 30, 2023$1.87B+4.9%
Q1 FY2023Mar 31, 2023$1.83B+10.1%
Q4 FY2022Dec 31, 2022$1.83B+2.7%
Q3 FY2022Sep 30, 2022$1.67B-0.9%
Q2 FY2022Jun 30, 2022$1.78B+1.0%
Q1 FY2022Mar 31, 2022$1.66B+3.9%
Q4 FY2021Dec 31, 2021$1.78B-14.8%
Q3 FY2021Sep 30, 2021$1.69B-12.6%
Q2 FY2021Jun 30, 2021$1.76B+43.8%
Q1 FY2021Mar 31, 2021$1.60B-10.2%
Q4 FY2020Dec 31, 2020$2.09B-1.9%
Q3 FY2020Sep 30, 2020$1.93B+1.9%
Q2 FY2020Jun 30, 2020$1.23B-38.3%
Q1 FY2020Mar 31, 2020$1.78B-9.7%
Q4 FY2019Dec 31, 2019$2.13B+2.6%
Q3 FY2019Sep 30, 2019$1.89B+3.0%
Q2 FY2019Jun 30, 2019$1.99B-0.9%
Q1 FY2019Mar 31, 2019$1.98B-2.1%
Q4 FY2018Dec 31, 2018$2.07B+0.1%
Q3 FY2018Sep 30, 2018$1.84B+1.3%
Q2 FY2018Jun 30, 2018$2.01B+3.0%
Q1 FY2018Mar 31, 2018$2.02B+2.3%
Q4 FY2017Dec 31, 2017$2.07B+2.7%
Q3 FY2017Sep 30, 2017$1.81B-1.1%
Q2 FY2017Jun 30, 2017$1.95B–
Q1 FY2017Mar 31, 2017$1.97B–
Q4 FY2016Dec 31, 2016$2.01B–
Q3 FY2016Sep 30, 2016$1.83B–

More Zimmer Biomet figures

See a number that looks wrong?